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ABSTRACT
Purpose: Evaluation of the viability of a random pattern dorsal skin flap, in rats with experimentally induced diabetes
mellitus. Methods: Thirty adult, male, Wistar EPM rats were distributed, at random, in two groups: I - Control (flap
elevation) and II - Experimental (flap elevation ten days after alloxan induced diabetes ). Results: The mean areas of
necrosis in the different groups were 36.4% (Control) and 52.1% (Experimental). Conclusion: The random pattern dorsal
skin flap was less viable in the diabetic rats.
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RESUMO
Objetivo: Avaliar a viabilidade do retalho cutâneo randômico dorsal em ratos experimentalmente induzidos ao diabetes
mellitus. Métodos: Foram utilizados 30 ratos Wistar, adultos, machos, distribuídos em 2 grupos: I – controle – submetidos
somente ao retalho cutâneo e II – experimental – submetidos ao retalho cutâneo após 10 dias da indução do diabetes
mellitus com aloxano. Resultados: O grupo controle teve 36,39% e o grupo experimental 52,06% de média de área de
necrose. Conclusão: A viabilidade do retalho cutâneo randômico dorsal foi menor no rato diabético do que no rato normal.
Descritores: Diabetes mellitus. Retalho cutâneo.  Aloxano. Ratos.
Introduction
Due to its high prevalence and potential deleterious
effects on a patient´s physical and psychological state,
diabetes mellitus, which can result in a morbid condition, is
a major medical concern1, 2. According to the World Health
Organization (WHO) the number of diabetics has doubled
in the past few years and is expected to double once again
by the year 2025. Today, there are 160,000 diabetics worldwide,
10,000 only in Brazil, which makes the country the sixth in
the world rank3. In humans, diabetes mellitus is one of the
most prevalent conditions with spontaneous manifestation.
In animals, it can be induced by partial pancreatectomy or
by the administration of diabetogenic drugs such as alloxan4.
These agents selectively destroy the Langerhans islet
â-cell. The best known drug-induced diabetes model is the
alloxan diabetes. Alloxan, a derivative of uric acid, as well as
of other substance of different chemical groups, cases â-
cells to degranulate and consequently degenerate1,5,6,7,8,9,10.
Skin flaps are largely used in all fields of plastic surgery,
especially in reconstructives11. They have been utilized for
centuries and, during this time, one concerning has been to
develop techniques to provide more assurance in skin flap
realization. The research of skin flaps survival mechanisms
and your possible curate factors have been issue for
publications12, 13, 14.
The purpose of this experimental study was to evaluate
the viability of a random pattern dorsal skin flap, in rats with
alloxan induced diabetes.
Methods
This study was approved by Commission of ethics in
Research of Federal University of Sao Paulo. All the
procedures followed, rigorously, the existent regulations
about animal experimentation. Thirty adult, male, Wistar
EPM rats, weighting around 300g, were distributed, at
random, in two groups of 15 animals: I – Control, exposed to
elevation of a skin flap; II – Experimental, exposed to flap
elevation ten days after alloxan induced diabetes. The animals
were individually allocated in cages, receiving standard food
and water ad libitum. Rats in Group II were kept in 48 hours
fast before diabetes induction. They were weighted and
anesthetized by her inhalation in glass dome.  A solution of
alloxan at 2 % diluted in saline at 0,9 % was administered to
the animals in a single dose corresponding to 40 mg of
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alloxan per Kg of animal weight injected into their penial
vein15 (Figure 1).
dimensions, was placed between the flap and its donor
bed17,18(Figures3,4). After that, the rats were placed in
individual cages, receiving food and water ad libitum. The
percentage of skin flap necrosis area was calculated on the
seventh postoperative day via the paper template method.
FIGURE 1 - Administration of a lloxan in the animal’s penial
vein.
In order to assess the effect of alloxan and to chemically
establish the diabetic condition, an incision was done in
any of the four veins in the tail of the rat using a 15 scalpel
blade 10 days after the diabetes induction. A sample of the
rat’s venous blood was collected on a reagent strip 10 days
after the diabetes induction procedure for blood glucose
level determination using a portable glucose analyzer15
(Figure 2).
FIGURE 2 - Portable blood glucose test device.
The level of serum glucose considered to be normal in
rattus novergicus ranges from 50 to 135 mg/100ml15. In this
study, rats with glucose levels above 200 mg/dl were
considered as having severe diabetes. After determination
of the glicemic state, the rats were weighted again and after
24 hours, anesthetized with Tiletamin Chloridrate (25 mg/kg)
and Zolazepam Chloridrate (25 mg/kg), intraperitoneally.
Then, the animals were positioned over a flat surface, with
extended limbs, their backs were shaved and a random
pattern, cranially based dorsal skin flap was elevated.
Delineation of the flap was done in the dorsum of the rats by
means of a transparent plastic pattern, cut in the standard
dimensions (4 x 10 cm). The flap was then incised with
scalpel, being elevated in a plane superficial to the deep
muscular fascia, including the superficial fascia, paniculum
carnosum, subcutaneous tissue and skin16. After flap
elevation, an impermeable plastic barrier, cut in the same
FIGURE 3 – Random skin flap raised.
FIGURE 4 – Suture with 4-0 nylon stitches after the flap
was raised and a plastic barrier was interpositioned.
The limit between viable tissue characterized by soft skin,
rosy, warm and with hair and necrotic tissue by stiff skin,
dark, cool and without hair was demarcated in the animals16
(Figures 5,6). A mould of entire flap was drawn and cut in
transparent paper, being checked in a precision balance (+/
- 0,001g error). It was cut from this fragment just the
correspondent area to flap necrosis that was also checked.
After that, it was used the following formula:
Considering the nature of the data involved in this
study, like percentage of necrosis, non parametric tests were
used in the statistical analysis. The Mann-Whitney test (non
parametric, independent groups) was used to compare
groups 1 and 2 as regards the percentages of necrosis in
the flaps. The significance level was fixed in 0.05 or 5% (<0.05).
Significant values were marked (*); non significant values were
identified as N.S.. The weights of the animals in the immediate
preoperative period were compared using the “t” Student’s
test for independent groups (parametric, non paired).
Percentage of necrosis
area of the flap
weight of paper template
of flap necrosis
weight of paper template
of total area of flap
 x 100=
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Results
All the alterations caracteristic of a diabetic rat were
observed, like polydipsia, polyuria, weight loss, asthenia,
dehydration and weight loss. Alongside with all these signs,
the percentages of necrosis in the control animals varied from
24.2 to 46.9% (mean 36.4%) and in the diabetic animals ranged
between 35.5 and 54.9% (mean 52.1%) (Table 1,  Figure 7).
FIGURE 6 - Necrotic tissue (experimental animal).
TABLE 1 - Percentages of necrosis in the seventh
postoperative day (%).
Control Group Experimental Group
48,43 58,42
34,71 66,95
48,79 61,24
20,80 53,32
48,15 51,85
31,06 39,72
33,14 35,50
46,82 54,00
43,10 48,87
24,25 60,69
25,52 54,90
40,42 48,31
30,15 65,21
37,78 40,17
32,85 41,80
Mean 36,39 52,06
SD 9,29 9,65
“t” Test for independent groups / t calculated + 4.53
(p<0.001)* / G1 < G2*
FIGURE 7 - Mean percentages of necrosis in the seventh
postoperative day (%).
FIGURE 5 - Necrotic tissue (control animal).
Discussion
Experimental diabetes induced by chemical agents,
such as alloxan, causes kidney lesions that are similar to
human diabetic nephropathy. It is a derivative of uric acid,
able to induce permanent diabetes in animals after 24 hours,
due to its selective toxic effect on beta pancreatic cells,
leading to a primary insulin insufficiency of the pancreas21,
22. Alloxan may be administered intravenously,
intraperitoneally or subcutaneously, but in the present study
the intravenous route was chosen, based on the rapidity of
the effect and the possibility of using a lower dose of this
toxic substance. Alloxan, once administered intravenously,
leads to diabetes by means of destruction of the pancreatic
insular tissue, including the beta cells that produce insulin,
which suffer degenerative alterations and necrosis. The result
is a diabetic animal, an excellent experimental model to study
organic alterations developed by insulin deficiency19.
Among the complications related to diabetes is tissular
healing impairment. In diabetic patients, protein synthesis
is reduced while catabolism is increased, with changes in
the tissues’ growing process, regeneration and reparation.
Healing is altered due to problems in the proteic metabolism
and fibroblasts depression. Skin flaps represent, often, the
only adequate option for surgical repair after removal of
skin lesions and tumors, specially when larger
reconstructions are necessary, demanding adequate
functional and aesthetic results.
The most common complication after reconstructions
with flaps is partial necrosis3, 4. This undesirable event
demands more operative procedures, increasing
hospitalization period and delaying the patients return to
normal activities. Failure in the operation may make new
reparation very difficult and mine the surgeon-patient
relationship17. The most important aspect that rules the
viability of a skin flap is adequate nutritive blood flow in the
microcirculation.
In the present study, Control animals (Group I) had
blood glucose levels between 60 and 94 mg/ml, what
according to the literature indicate normal rats, while
Experimental animals (Group II) had glucose levels between
212 and 418 mg/ml, evidencing an uncontrolled diabetic state.
Besides hyperglycemia, it was observed that rats that
received alloxan presented clinic signs of the disease, similar
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to those described for humans, polydipsia (abnormal thirst),
polyuria (increased urine volume), weight loss (due to lean
mass loss), asthenia (weakness due to the inability to use
glucose as a source of energy), dehydration (due to the
animal body’s attempt to get rid of the excess blood glucose
as the normal process of storing glucose in the body cells is
impaired) and weight loss1.
The dorsal random pattern skin flap, cranially based, in
the rat, used in the present work, was described by
McFarlane et al.16, as an experimental flap model to study
skin necrosis and its prevention. Dimensions are 10 x 4 cm.
Usually, it is associated with a distal necrosis rate between
25 and 50%, but in 5.7% of the animals there is no significant
necrosis. In the herein presented study, percentages of
necrosis in control animals (Group I) ranged between 20.8
and 48.4% (mean 36.4%). In the experimental rats (Group II),
the values ranged between 35.5 and 65.2% (mean 52.1%).
Statistical analysis showed a significant difference between
these groups. Uncontrolled diabetes increased the
percentage of distal necrosis in this flap in relation to normal
rats. Future perspectives involve the use of drugs able to
reduce distal necrosis in this random skin flap in uncontrolled
diabetic rats.
Conclusion
Uncontrolled diabetes reduced the viability of this
random pattern skin flap in the rat.
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